Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001079973-13-000060
Filing Date
2013-01-25
Accepted
2013-01-25 16:30:30
Documents
1
Period of Report
2013-01-23

Document Format Files

Seq Description Document Type Size
1 appy_landon.html 4  
1 appy_landon.xml 4 4318
  Complete submission text file 0001079973-13-000060.txt   5790
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3868 MOCKINGBIRD LN DALLAS TX 75205
Business Address
LANDON JOHN H (Reporting) CIK: 0001200624 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33675 | Film No.: 13549066